Breast cancer more likely to be advanced stage disease at diagnosis in women with diabetes
the ONA take:
A new study by the Institute for Clinical Evaluative Sciences (ICES) and Women’s College Hospital demonstrates that breast cancer in women with diabetes is more likely to be advanced stage at diagnosis.
The researchers reviewed cases of new invasive breast cancer diagnoses in women ages 20 to 105 years made between 2007 and 2012.
In the study, 6,115 of more 38,000 women (15.9%) had diabetes. These women were 14% more likely to present with stage II breast cancer, 21% more likely to present with stage III breast cancer, and 16% more likely to present with stage IV disease than to present with stage I.
Women with diabetes also had higher risk of lymph node metastases. In addition, mammography rates were lower among women with diabetes, possibly accounting for later stage disease at diagnosis.
Stage II or III breast cancer at diagnosis translates into a 15% decrease in 5-year survival at the time of diagnosis for these patients.
The researchers suggest that breast cancer screening practices may need to be modified for women with diabetes to reduce later-stage detection.
Breast cancer in women with diabetes is more likely to be advanced stage at diagnosis.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|